HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of HLA class I, beta(2)-microglobulin and HLA class II antigens in primary orbital melanoma.

Abstract
Major histocompatibility antigens (MHC) play a crucial role in the recognition of tumor cells by the immune system. There is not much information on the role of MHC molecule expression in primary orbital melanomas. In the present study, the authors examined the expression of human leukocyte antigen (HLA) class I, beta(2)-microglobulin (beta(2)-m) and HLA class II antigens in primary orbital melanoma and correlated this with the clinical and pathological findings. HLA class I antigen, beta(2)-m and HLA class II antigen expression were evaluated immunohistochemically in three primary orbital melanomas and correlated with cell type and metastasis. Immunohistochemistry showed heterogeneous expression of HLA class I, beta(2)-m and HLA class II antigen in two cases with no liver metastasis and negative expression in one case with liver metastasis. This preliminary observation deserves further investigation, which may shed more light on the immune escape mechanisms of this tumor and thus make possible novel therapeutic strategies.
AuthorsSubramanian Krishnakumar, Sundaram Lakshmi, Dhiraj Abhyankar, Jyotirmay Biswas
JournalOrbit (Amsterdam, Netherlands) (Orbit) Vol. 22 Issue 4 Pg. 257-63 (Dec 2003) ISSN: 0167-6830 [Print] England
PMID14685899 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Histocompatibility Antigens Class I
  • Histocompatibility Antigens Class II
  • beta 2-Microglobulin
Topics
  • Female
  • Histocompatibility Antigens Class I (metabolism)
  • Histocompatibility Antigens Class II (metabolism)
  • Humans
  • Immunoenzyme Techniques
  • Male
  • Melanoma (metabolism)
  • Orbital Neoplasms (metabolism)
  • beta 2-Microglobulin (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: